case_images: PMC11760832_01
case_images: MRI SAG T2 sequence: cervical uterine hypointense lesion without gadolinium enhancement. (A) Contract CT. Arterial-phase retroperitoneal adenopathy (B).
case_images: biomedicines-13-00083-g001.jpg
case_images: PMC11760832_01_biomedicines-13-00083-g001.jpg
case_images: biomedicines-13-00083-f001
case_images: All the manifestations of the observed results are mentioned in detail in Figure 1.
case_images: Microscopic examinations reveal a tumoral proliferation composed of nests of tumoral cells, separated by fine bands of connective tissue; the neoplastic cells are of medium size, irregular cellular birders, eosinophilic cytoplasm, and oversized hyperchromatic nuclei with moderate atypia, consistent with the diagnosis of a non-keratinized squamous cell carcinoma that is moderately differentiated (A): microscopic examination x4, (B): microscopic examination x20.
case_images: biomedicines-13-00083-g002.jpg
case_images: PMC11760832_01_biomedicines-13-00083-g002.jpg
case_images: biomedicines-13-00083-f002
case_images: After performing the biopsy from the cervix, the histopathological diagnosis of non-keratinized squamous carcinoma of the cervix G2 was confirmed (Figure 2).
case_images: First FDG PET/CT examination. High FDG uptake in uterine cervical lesion (A,B), left para-aortic retroperitoneal (C), and left pelvic (external iliac) (D) adenopathies, both with FDG uptake.
case_images: biomedicines-13-00083-g003.jpg
case_images: PMC11760832_01_biomedicines-13-00083-g003.jpg
case_images: biomedicines-13-00083-f003
case_images: No other changes in pathology or FDG uptake were clearly seen (Figure 3).
case_images: Second FDG PET/CT. Discrete progression in the uterine cervical tumor (A,B), as well as progression in the left aortic retroperitoneal adenopathy (C), but with remission of the left external iliac nodules (D).
case_images: biomedicines-13-00083-g004.jpg
case_images: PMC11760832_01_biomedicines-13-00083-g004.jpg
case_images: biomedicines-13-00083-f004
case_images: No new detectable or FDG uptake lesions were observed (Figure 4).
case_images: Last FDG PET/CT performed. Complete metabolic remission of the uterine cervical tumor (A,B), as well as the disappearance of the retroperitoneal (C) and left external iliac (D) adenopathies.
case_images: biomedicines-13-00083-g005.jpg
case_images: PMC11760832_01_biomedicines-13-00083-g005.jpg
case_images: biomedicines-13-00083-f005
case_images: No pelvic or inguinal lymphadenopathy, morphological changes, or FDG activity were detectable (Figure 5).